NCT01805804View on ClinicalTrials.gov

Valsartan to Prevent Left Ventricle Remodeling in Pacemaker Patients

PHASE4TerminatedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

January 31, 2019

Study Completion Date

January 31, 2019

Conditions
First Time Dual Chamber Pacemaker Implantation
Interventions
DRUG

placebo/valsartan

Trial Locations (1)

41-800

II Dept. of Cardiology in Zabrze Medical University of Silesia, Zabrze

Sponsors
All Listed Sponsors
collaborator

Polpharma Pharmaceutical Company

UNKNOWN

lead

Medical University of Silesia

OTHER

NCT01805804 - Valsartan to Prevent Left Ventricle Remodeling in Pacemaker Patients | Biotech Hunter | Biotech Hunter